Biotech · Private company
Navidea Biopharmaceuticals
Track this companyFree. Adds Navidea Biopharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials110 recruiting or active
Pipeline programs15From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline15
- TC99m-tilmanoceptPhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- [18F]NAV4694Phase 2 · Mild Cognitive ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- SPECT Imaging (180 Minutes post-injection)Phase 2 · Arthritis, RheumatoidClinicalTrials.gov · fetched Nov 12, 2026
- SPECT Imaging (60 Minutes post-injection)Phase 2 · Arthritis, RheumatoidClinicalTrials.gov · fetched Nov 12, 2026
- Tc 99m tilmanoceptPhase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Tc99m-tilmanoceptPhase 2 · Arthritis, RheumatoidClinicalTrials.gov · fetched Nov 12, 2026
- Whole body planar SPECT imaging (15 Minutes post-injection)Phase 2 · Arthritis, RheumatoidClinicalTrials.gov · fetched Nov 12, 2026
- Whole body planar SPECT imaging (180 Minutes post-injection)Phase 2 · Arthritis, RheumatoidClinicalTrials.gov · fetched Nov 12, 2026
- Whole body planar SPECT imaging (60 Minutes post-injection)Phase 2 · Arthritis, RheumatoidClinicalTrials.gov · fetched Nov 12, 2026
- SPECT/CT ImagingPhase 1 · Liver MetastasesClinicalTrials.gov · fetched Nov 12, 2026
- Tc 99M Sulfur ColloidPhase 1 · Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- Tc99m-tilmanoceptPhase 1 · Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- Tc99m-tilmanoceptPhase 1 · Kaposi SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- TilmanoceptPhase 1 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Tilmanocept (Technetium Tc 99m tilmanocept Injection)Phase 1 · Liver MetastasesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RAPHASE3 · TERMINATED · started Mar 2, 2022ClinicalTrials.gov NCT05246280 · fetched Nov 12, 2026
- Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RAPHASE2 · TERMINATED · started Sep 14, 2021ClinicalTrials.gov NCT04078191 · fetched Nov 12, 2026
- Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m TilmanoceptPHASE2 · COMPLETED · started May 27, 2021ClinicalTrials.gov NCT04947137 · fetched Nov 12, 2026
- Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar ImagingPHASE2 · COMPLETED · started Apr 8, 2019ClinicalTrials.gov NCT03938636 · fetched Nov 12, 2026
- Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASHPHASE1 · TERMINATED · started Dec 6, 2017ClinicalTrials.gov NCT03332940 · fetched Nov 12, 2026
- An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)PHASE1 · COMPLETED · started Dec 1, 2017ClinicalTrials.gov NCT03157167 · fetched Nov 12, 2026
- An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.PHASE1 · TERMINATED · started Jul 26, 2017ClinicalTrials.gov NCT03029988 · fetched Nov 12, 2026
- Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RAPHASE1_PHASE2 · COMPLETED · started Jan 1, 2017ClinicalTrials.gov NCT02865434 · fetched Nov 12, 2026
- Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT ImagingPHASE1 · COMPLETED · started Jul 1, 2016ClinicalTrials.gov NCT02683421 · fetched Nov 12, 2026
- Use of 99mTc Tilmanocept for Imaging Arterial InflammationCOMPLETED · started Sep 1, 2015ClinicalTrials.gov NCT02542371 · fetched Nov 12, 2026
- Beta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCIPHASE2 · TERMINATED · started Mar 1, 2013ClinicalTrials.gov NCT01812213 · fetched Nov 12, 2026